Hidradenitis Suppurativa Phase 2b Study of Izokibep

NCT05355805 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

205

Enrollment

INDUSTRY

Sponsor class

Conditions

Hidradenitis Suppurativa

Interventions

DRUG: Izokibep
DRUG: Placebo to izokibep

Sponsor

ACELYRIN Inc.